Correlating physicochemical and biological properties to define critical quality attributes of a rAAV vaccine candidate.
Journal Information
Full Title: Mol Ther Methods Clin Dev
Abbreviation: Mol Ther Methods Clin Dev
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Medicine, Research & Experimental
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Declaration of interests L.H.V. is an inventor on AAVCOVID and AAV vaccine patent applications and a founder and employee of ciendias bio, a vaccine biotechnology company. N.Z. is an inventor on AAVCOVID and AAV vaccine patent applications."
"This work was supported, in whole or in part, by the 10.13039/100000865Bill & Melinda Gates Foundation (INV ID-021035). Under the grant conditions of the Foundation, a Creative Commons Attribution 4.0 Generic License has already been assigned to the Author Accepted Manuscript version that might arise from this submission. The authors would like to thank Saleh-Birdjandi Soraia from the Vaccine Analytics and Formulation Center at the University of Kansas for technical assistance."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025